AMERICAN SHARED HOSPITAL SERVICES Noncontrolling Interest, Increase from Subsidiary Equity Issuance
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $8.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-03-31 was $8.00K, a 78.95% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2024-03-31 was $38.00K.
- AMERICAN SHARED HOSPITAL SERVICES noncontrolling interest, increase from subsidiary equity issuance for fiscal 2025 was $8.00K, a 78.95% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES noncontrolling interest, increase from subsidiary equity issuance for fiscal 2024 was $38.00K.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|
| 2025-12-31 | $8.00K 10-K · filed 2026-03-31 | |
| 2025-03-31 | $8.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $38.00K 10-K · filed 2026-03-31 | |
| 2024-03-31 | $38.00K 10-Q/A · filed 2026-01-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |